Article
A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees.
Vaccine - 1 Jul 1994
Crowe J E, Bui P T, Davis A R, Chanock R M, Murphy B R
Abstract excerpt
A cold-passage (cp), temperature-sensitive (ts) RSV mutant designated RSV cpts-248 (shut-off temperature 38 degrees C), which possesses host-range mutations acquired during 52 passages at low temperature in bovine tissue culture and a ts phenotype introduced by subsequent chemical mutagenesis, was found previously to be attenuated, immunogenic, and protective against wild-type challenge in seronegative...
Topics
- Animals
- Cattle
- Cell Line, Transformed
- Chlorocebus aethiops
- Cold Temperature
- Culture Techniques
- Epithelial Cells
- Epithelium
- Female
- Fluorouracil
- Humans
